Ryan J. Watts, President and CEO at Denali Therapeutics Inc. (DNLI), sold 10,058 shares at $28.73 ($289K) on 2023-01-04, disclosed to the SEC on 2023-01-05.
Open-market sale of $289k DNLI by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.73 | 5,029 | $144K | 50.0% |
| 2 | $28.73 | 5,029 | $144K | 50.0% |
| Total | $28.73 avg | 10,058 | $289K | 100% |
| Filing → |
| DNLI | SELL | 2025-01-08 | $1.5M | — | Filing → |
| DNLI | SELL | 2024-10-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-22 | $108K | — | Filing → |